“…As formulating in 5% ethanol was not sufficient to prevent radiolysis in formulated products and also could not be employed to prevent radiolytic decomposition occurring during synthesis, alternative anti-oxidants were considered. A range of compounds are known to inhibit decomposition attributable to free radicals including ascorbic acid [Chen et al, 2005; Elmore, 2005; Liu et al, 2003; Werner et al, 1990], potassium iodide [Suzuki et al, 1990], nitrones [Reybier et al, 2006; Green et al, 2003] and thiourea [Halliwell and Gutteridge, 2005;]. Thiourea is highly toxic and unsuitable for clinical formulations and so we focused our efforts on ascorbic acid and nitrones as non-toxic anti-oxidants amenable for human use.…”